3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thyroid Nodule
1
Thyroid Neoplasms
1
Neoplastic Cells, Circulating
1
Lung Neoplasms
1
Disease
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
Gefitinib
9
Pemetrexed
7
Carboplatin
5
Gemcitabine
4
Cisplatin
4
apatinib
3
Docetaxel
3
aflutinib
2
Neoadjuvant Therapy
2
Erlotinib Hydrochloride
2
Bevacizumab
2
tislelizumab
1
pembrolizumab
1
motesanib diphosphate
1
lometrexol
1
icotinib
1
endostar protein
1
camrelizumab
1
Watchful Waiting
1
Thymalfasin
1
Radiomics
1
Platinum Compounds
1
Paclitaxel
1
Lymph Node Excision
1
Indium
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Folic Acid
1
Exome
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Adenocarcinoma of Lung
×
Anterior Temporal Lobectomy
×
Clear all
NCT02951897
2016-11-02
CTCs detection
Third Military Medical University
Phase NA
Unknown
120 enrolled